This article looks at contact urticaria in more detail, including its causes, risk factors, symptoms, and treatment. Contact urticaria is an immediate and short lived reaction to a certain ...

urticaria, vertigo, and motion sickness. Overdose of this medication, however, can cause ‘significant toxicity,’ and could lead to symptoms such as cardiac arrhythmias, rhabdomyolysis (a toxic ...

Drug rashes can be an unwanted side effect of many medications. Learn which medications can cause these skin reactions.

The skin comes in contact with a normally harmless substance that the ... There is evidence that treating the thyroid condition may also improve urticaria symptoms. If your urticaria is related to an ...

Gurugram: Morepen Laboratories Limited has received approval from the Center for Drug Evaluation (CDE) of the National ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced 11 presentations will be shared at the American Academy of Neurology (AAN) 2025 Annual Meeting, taking place April 5-9 in San Diego, CA, and ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

Paris: Sanofi has received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the treatment ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.